When given the chance to earn $24,000 for four days consultation on the purchase of a biotechnology company, Ben Candidi jumped at it. Sure, the novice scientist could check out the Miami company's data and patents and advise his Boston client whether the anti-cancer compounds were worth their $20 million price tag. The animal test data look fantastic. But when Ben finds the Miami company's disagreeable inventor collapsed in a heap, cold and dead, Ben wonders who could conceivably profit from his death. Ben launches a deeper inquiry which leaves him struggling for his life.